BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe
The Future of Genomics: GeneDx (WGS) Achieves Profitability & Expands Market Reach

Maxwell Biosciences, Makers of CLAROMER, Hire John Lord, Ph.D., as VP of Research and Development

  • BioTech Health X
  • May 6, 2021
Austin, Texas based biotechnology company Maxwell Biosciences have announced the hiring of Dr. John Lord as Vice President…
Read More
0 Shares
0
0
0
0
0
0
0
Former Lilly CEO Josh Bilenker & Former Novartis Head of Oncology Jeff Engelman Announce Treeline Biosciences

Ex-Lilly CEO Josh Bilenker & Ex-Novartis Head of Oncology Jeff Engelman Announce Treeline Biosciences

  • BioTech Health X
  • April 30, 2021
Two powerhouse executives have joined forces to form a brand new cancer Biotech company. Josh Bilenker, M.D., and…
Read More
0 Shares
0
0
0
0
0
0
0
Repertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery T Cell Receptors

Repertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery & T Cell Receptors

  • BioTech Health X
  • April 29, 2021
The collaboration between Repertoire and Yale seeks to identify novel antigenic reactivity of T cells in patients with…
Read More
0 Shares
0
0
0
0
0
0
0
Welcome To BioTech Health X

Welcome To BioTech Health X

  • BioTech Health X
  • April 28, 2021
The New Leader in BioTech News, BioTech Stock Information & BioTech Industry Analysis BioTech Health X delivers the…
Read More
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Is Catalyst Pharmaceuticals (CPRX) a Smart Rare Disease Stock to Buy for Long-Term Growth?
  • Could Ocular Therapeutix (OCUL) Be a Smart Long-Term Bet in Ophthalmology?
  • Could Aurinia Pharmaceuticals (AUPH) Be a Smart Long-Term Buy After Its Recent Struggles?
  • Is Arcutis Biotherapeutics (ARQT) One of the Most Underrated Biotech Stocks Right Now?
  • Is Trevi Therapeutics (TRVI) the Hidden Biotech Stock Investors Are Missing?
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • June 14, 2026
    Is Catalyst Pharmaceuticals (CPRX) a Smart Rare Disease Stock to Buy for Long-Term Growth?
    • June 14, 2026
    Could Ocular Therapeutix (OCUL) Be a Smart Long-Term Bet in Ophthalmology?
    • June 14, 2026
    Could Aurinia Pharmaceuticals (AUPH) Be a Smart Long-Term Buy After Its Recent Struggles?
    • June 14, 2026
    Is Arcutis Biotherapeutics (ARQT) One of the Most Underrated Biotech Stocks Right Now?
    • June 14, 2026
    Is Trevi Therapeutics (TRVI) the Hidden Biotech Stock Investors Are Missing?
Recent Posts
  • Is Iovance Biotherapeutics (IOVA) a Good Cancer Immunotherapy Stock to Buy Now?
    • June 14, 2026
  • Is Nurix Therapeutics (NRIX) the Kind of Cancer Stock Wall Street Is Sleeping On?
    • June 14, 2026
  • Is Edgewise Therapeutics (EWTX) a Good Long-Term Bet for Biotech Investors?
    • June 14, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (978)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top